Difference between revisions of "Part:BBa K1699001"
Line 18: | Line 18: | ||
<br />1. hTERT GFP - robust transcription of GFP in all HepG2 cells. None detected in control (human fibroblasts). | <br />1. hTERT GFP - robust transcription of GFP in all HepG2 cells. None detected in control (human fibroblasts). | ||
<br />2. hTERT dCas9-VP64 - activation system including gRNA under survivin promoter. Activation system worked in cancer cells and not in healthy ones. | <br />2. hTERT dCas9-VP64 - activation system including gRNA under survivin promoter. Activation system worked in cancer cells and not in healthy ones. | ||
+ | |||
+ | ===References=== | ||
+ | |||
+ | 1. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters | ||
+ | http://www.nature.com/gt/journal/v8/n7/pdf/3301421a.pdf | ||
Revision as of 13:37, 10 September 2015
Human short TERT promoter
Human short TERT promoter.
hTERT (human Telomerase Reverse Transcriptase) is a human promoter which controls the transcription of Telomerase, a gene highly expressed in cancer cells, and not in healthy ones (1).
Usage and Biology
hTERT promotes the transcription of the catalytic subunit of telomerase. Telomerase elognates the ends of chromosomes, regions called telomers. hTERT is not active in somatic cells and appears to be highly active in most if not all cancer cells, therefor, cells that will express an exogenic gene under hTERT are likely to be cancerous. We have used this promoter as part of a two promoter system, in order to detect whether a cell was a cancer cell.
Characterization
This part was used by BGU 2015 team in a couple of constructs. Promoter activation worked in all of them.
1. hTERT GFP - robust transcription of GFP in all HepG2 cells. None detected in control (human fibroblasts).
2. hTERT dCas9-VP64 - activation system including gRNA under survivin promoter. Activation system worked in cancer cells and not in healthy ones.
References
1. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters http://www.nature.com/gt/journal/v8/n7/pdf/3301421a.pdf
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]